Metavert synergises with standard cytotoxics in human PDAC organoids and is associated with transcriptomic signatures of therapeutic response

An J, Kurilov R, Peccerella T, et al. Metavert synergises with standard cytotoxics in human PDAC organoids and is associated with transcriptomic signatures of therapeutic response (PMID: 39217851). Transl Oncol. Epub 2024.

Is this what the future of cancer research looks like?

Cancer: Researchers search for reasons for therapy resistance

Mamma Mia! Explanatory videos on CATCH / COGNITION

Interview Andreas Trumpp: Overcoming resistance

FutureXChange – The Future Forum of the National Decade Against Cancer Project pitch SATURN3 by Jens Siveke

Focus on tumor heterogeneity in difficult-to-treat cancers

Better combating resistant cancer cells

Better combating resistant cancer cells

Involving patients (Publication in einblick – The Journal of the German Cancer Research Center, Issue 1 | 2022)